Gelonghui May 5 丨 Sunflower Pharmaceutical (002737)(002737chippoker.SZ) AnnouncementchippokerHarbin Kuihua Pharmaceutical Co., Ltd.(hereinafter referred to as "Harbin Kuihua"), a wholly-owned subsidiary of the company, recently received the "Acceptance Notice" issued by the State Food and Drug Administration on the application for registration and marketing authorization of Compound Polyethylene Glycol (3350) Electrolyte Powder. Proposed indication (or function indication) of the drugchippoker: For the treatment of chronic constipation in children aged 1 to 11 and fecal impaction in children aged 5 to 11.
